Generic Drugs: Global collaboration opportunities

NEW YORK, Feb. 3, 2014 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:

Generic Drugs: Global collaboration opportunities

http://www.reportlinker.com/p0703654/Generic-Drugs-Global-collaboration-opportunities .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Generic_Drug

Key facts, statistics and insights on 160 medium-sized generic manufacturers based in 42 countries!

Collaboration is the key to growth With the recent economic turmoil affecting many markets around the world, the generic and branded sectors face similar problems

At one time the generic sector was seen as a valuable way to bring effective products to a wider audience This, allied to the rising cost of new advanced branded products, led to rapid expansion of the generics sector Even markets traditionally based in the provision of branded medicines have made moves to increase generic prescribing

But pressure on health spending is seeing downward pressure on generic prices With lower margins this is creating pain for generics companies

SME Generic companies offer focused opportunities

With established markets compromised, where can the industry go? Expansion in the sector has been seen through more partnering, either through outright acquisition to increase market share or through product and marketing licensing Being bigger and having improved market access is seen as a way of distributing cost and strengthening revenues While major players such as Teva and Sandoz play an international role, there are a number of established and progressive generic manufacturers worthy of consideration

Use this report to…

Identify commercial partners to secure new markets, technologies and revenues

Assess merger and acquisition targets

Understand the developing generic industry in key markets worldwide

Profile the competitive environment in the increasingly important medium-sized company sector

Seek out companies manufacturing/marketing similar product lines

Assess the investment potential of these key companies

Find and assess potential partners and acquisition targets with this report

This new report from Espicom is a key resource for the wide assessment of 160 medium-sized generic companies operating in 42 markets worldwide The report provides an essential and comprehensive evaluation of each company:

Location, establishment and full contact details Financial information, where available Products and/or therapy areas Recent strategic alliancesDelivering the key content you need

• Background

A summary of the company's foundation and main business interests

• Product rangeDetails of ANDAs approved or products/therapy areas represented

• Financial

Financial performance or funding data

• Strategic alliancesDetails of significant marketing and supply agreements

• Contact information

Postal, telephone, fax and website details

About the Author:

Generic Drugs: Global Collaboration Opportunities has been researched and written by Espicom editor Ian Platts In addition to this report, Ian edits the leading newsletter World Generic Markets and has monitored the generics market for over 10 years

Other reports in the series:

World Generic Market Report

(June 2013) VOLUME I: COMPANY PROFILES & VOLUME II: COUNTRY PROFILES

A complete global analysis of the prospects for markets and companies in this dynamic industry sector

Biosimilar Opportunities in an Evolving Market

(August 2013)

The long awaited promise of biosimilars takes another step to fulfilment with the first approval in Europe of high-value second generation products But what products can be expected to follow, who is developing them and what are the hot prospects?

Inhalation & Nasal Spray Generic Drugs

(November 2013)

Comprehensive overview of the challenges and opportunities across the respiratory drugs market, and the FDA's new product guidance forgeneric inhalers

Contents

Companies In This Report1Company Details In Focus8Argentina17Laboratorios Phoenix17Snapshot 17Background 17Products 17Major Developments 17Contact Details18Australia 19Alchemia19Snapshot 19Background19Products19Financials20Major Developments20Contact Details21Bangladesh22Beximco Pharmaceuticals 22Snapshot 22Background22Products22Financials23Major Developments23Contact Details24Brazil 25Hypermarcas25Snapshot 25Background25Products25Financials25Major Developments26Contact Details27LAFEPE28Snapshot 28Background28Products28Major Developments29Contact Details29moksha830Snapshot 30Background30Products30Major Developments30Contact Details31Bulgaria32Sopharma32Snapshot 32Background32Products32iiiGeneric Drugsiv

Financials32

Contact Details33

Canada 34

AA Pharma34

Snapshot 34

Background34

Products34

Contact Details35

BioVectra 36

Snapshot 36

Background36

Products36

Major Developments36

Contact Details37

Intellipharmaceutics International 38

Snapshot 38

Background38

Products38

Financials38

Major Developments39

Contact Details40

Chile41

CFR Pharmaceuticals 41

Snapshot 41

Background41

Products42

Financials42

Major Developments42

Contact Details43

China 44

Aoxing Pharmaceutical44

Snapshot 44

Background 44

Products 44

Financials 44

Major Developments45

Contact Details 46

China Pharma Holdings 47

Snapshot 47

Background47

Products47

Financials47

Contact Details 48

Rxmidas/GRMIDAS 49

Snapshot 49

Background49

Products49

Financials49

Major Developments49

Contact Details50

Zhejiang Huahai Pharmaceuticals 51

Snapshot 51

Background51

v

Products51Contact Details51Cyprus 52Medochemie 52Snapshot 52Background52Products52Contact Details52Egypt 53EIPICo 53Snapshot 53Background53Products53Contact Details53France 54BioAlliance Pharma54Snapshot 54Background54Financials55Major Developments55Contact Details57Germa ny 58Alfred E Tiefenbacher (AET) 58Snapshot 58Background58Products58Major developments58Contact Details59Fresenius Kabi60Snapshot 60Background60Products60Financials 62Major Developments62Contact Details 64Greece 65Genepharm 65Snapshot 65Background65Products65Contact Details66Pharmathen 67Snapshot 67Background67Products67Financials67Contact Details67India 68Alembic 68Snapshot 68Background68vi

Products68

Financials69

Major Developments70

Contact Details71

Alkem 72

Snapshot 72

Background72

Products72

Major Developments73

Contact Details73

Bafna Pharmaceuticals 74

Snapshot 74

Background74

Products74

Financials75

Major Developments75

Contact Details76

Bharat Serums and Vaccines 77

Snapshot 77

Background77

Products77

Contact Details78

Biocon 79

Snapshot 79

Background79

Products79

Financials80

Major Developments81

Contact Details83

Claris Lifesciences84

Snapshot 84

Background 84

Products 84

Financials85

Major Developments86

Contact Details87

Emcure88

Snapshot 88

Background88

Products88

Major Developments89

Contact Details89

Gland Pharma90

Snapshot 90

Background90

Products90

Major Developments90

Contact Details91

Glenmark Pharmaceuticals 92

Snapshot 92

Background92

Products92

Financials94

Major Developments96

Contact Details97

vii

Granules India 98Snapshot 98Background98Products98Financials99Major Developments99Contact Details99Hetero Drugs100Snapshot 100Background 100Products 100Major Developments 101Contact Details 103Indoco Remedies 104Snapshot104Background 104Products104Financials 105Major Developments 105Contact Details 106Intas Pharmaceuticals 107Snapshot107Background 107Products107Financials 108Major Developments 108Contact Details 109Ipca Laboratories110Snapshot110Background 110Products110Financials 110Contact Details 112JB Chemicals & Pharmaceuticals 113Snapshot113Background 113Products113Financials 113Major Developments 114Contact Details 115Jubilant Life Sciences 116Snapshot116Background 116Products116Financials 117Major Developments 118Contact Details 119Macleods Pharmaceuticals 120Snapshot120Background 120Products120Contact Details 121Marksans Pharma 122Snapshot122Background 122viii

Products122

Financials 122

Contact Details 123

Micro Labs 124

Snapshot124

Background 124

Products124

Major Developments 124

Contact Details 125

Natco Pharma 126

Snapshot126

Background 126

Products126

Financials 127

Major Developments 128

Contact Details 130

Orchid Chemicals & Pharmaceuticals 131

Snapshot131

Background 131

Products131

Financials 133

Major Developments 133

Contact Details 134

RPG Life Sciences 135

Snapshot135

Background 135

Products135

Financials 135

Major Developments 136

Contact Details 136

Shasun Pharmaceuticals 137

Snapshot137

Background 137

Products137

Financials 137

Major Developments 138

Contact Details 139

Strides Arcolab140

Snapshot140

Background 140

Products140

Financials 142

Major Developments 143

Contact Details 145

Torrent Pharmaceuticals 146

Snapshot146

Background 146

Products146

Financials 147

Major Developments 148

Contact Details 149

Unichem Laboratories 150

Snapshot150

Background 150

Products150

ix

Financials 151Major Developments 152Contact Details 152Venus Remedies 153Snapshot153Background 153Products153Financials 153Major Developments 154Contact Details 154Ireland155Consilient Health 155Snapshot155Background 155Products155Contact Details 156Reliance GeneMedix 157Snapshot157Background 157Products157Financials 157Major Developments 158Contact Details 159Italy 160ACS Dobfar160Snapshot160Background 160Products160Contact Details 161Japa n 162Nichi-Iko Pharmaceutical 162Snapshot162Background 162Products162Financials 162Major Developments 163Contact Details 163Nippon Chemiphar 164Snapshot164Background 164Products164Financials 164Contact Details 165Towa Pharmaceutical166Snapshot166Background 166Products166Financials 166Contact Details 167Jorda n 168Hikma Pharmaceuticals168Snapshot168x

Background 168

Products168

Financials 171

Major Developments 171

Contact Details 175

Kenya176

Regal Pharmaceuticals 176

Snapshot176

Background 176

Products176

Contact Details 176

La tvia 177

Grindeks 177

Snapshot177

Background 177

Products177

Financials 177

Major Developments 178

Contact Details 179

Lithuania 180

Sanitas180

Snapshot180

Background 180

Products180

Financials 181

Major Developments 182

Contact Details 182

Malaysia 183

CCM Pharmaceuticals 183

Snapshot183

Background 183

Products183

Financials 184

Major Developments 184

Contact Details 185

Malaysia 186

Inno Biologics 186

Snapshot186

Background 186

Products186

Contact Details 187

Pharmaniaga Berhad188

Snapshot188

Background 188

Products188

Financials 188

Major Developments 189

Contact Details 189

Mexic o 190

Genomma Lab190

Snapshot190

xi

Background 190Products190Financials 190Contact Details 191Netherlands 192Genmed Holding 192Snapshot192Background 192Products192Financials 192Major Developments 193Contact Details 193Synthon194Snapshot194Background 194Products194Major Developments 195Contact Details 196New Zealand 197Douglas Pharmaceuticals 197Snapshot197Background 197Products197Financials 197Contact Details 198Norway 199Navamedic199Snapshot199Background 199Products199Financials 200Major Developments 200Contact Details 201Oma n 202Oman Pharmaceutical Products202Snapshot 202Background 202Products 202Major Developments 202Contact Details 203Poland 204Polpharma 204Snapshot 204Background 204Products 204Major Developments 204Contact Details 206Portugal 207Hovione207Snapshot 207Background 207xii

Products 207

Financials 208

Major Developments 208

Litigation 208

Contact Details 208

Roma nia 209

Antibiotice 209

Snapshot 209

Background 209

Products 209

Financials 209

Major Developments 210

Contact Details 210

Russia 211

R-Pharm211

Snapshot211

Background 211

Products211

Financials 211

Major Developments 212

Contact Details 212

South Africa 213

Adcock Ingram 213

Snapshot213

Background 213

Products214

Financials 216

Major Developments 218

Contact Details 221

Cipla Medpro222

Snapshot 222

Background 222

Products 222

Financials 223

Major Developments 224

Contact Details 225

Litha Healthcare226

Snapshot 226

Background 226

Products 226

Financials 226

Major Developments 227

Contact Details 228

Pharma Dynamics229

Snapshot 229

Background 229

Products 229

Contact Details 229

Sonke Pharmaceuticals230

Snapshot 230

Background 230

Products 230

Major Developments 230

xiii

Contact Details 231South Korea 232Hanmi Pharmaceutical232Snapshot232Background 232Products232Financials 233Major Developments 234Contact Details 236Spai n 237Laboratorios Cinfa237Snapshot237Background 237Products237Financials 237Major Developments 238Contact Details 238Sweden 239Bluefish Pharmaceuticals239Snapshot 239Background 239Products 239Financials 239Major Developments 240Contact Details 241Switzerland 242Acino242Snapshot 242Background 242Products 242Financials 243Major Developments 243Contact Details 245Legacy Pharmaceuticals International 246Snapshot 246Background 246Products 246Contact Details 246Tai wan 247ScinoPharm Taiwan 247Snapshot247Background 247Products 248Financials 248Major Developments 249Contact Details 250Thailand 251Government Pharmaceutical Organisation251Snapshot251Background 251Products251xiv

Contact Details 252

Turkey 253

Abdi Ibrahim253

Snapshot253

Background 253

Products253

Major Developments 254

Contact Details 254

EastPharma255

Snapshot255

Background 255

Products255

Financials 255

Contact Details 256

Mustafa Nevzat Pharmaceuticals 257

Snapshot257

Background 257

Products257

Major Developments 258

Contact Details 258

UK 259

Amdipharm Mercury (AMCo)259

Snapshot 259

Background 259

Products 260

Financials 260

Major Developments 261

Contact Details 261

Kent Pharmaceuticals262

Snapshot 262

Background 262

Products 262

Major Developments 262

Contact Details 263

Syntropharma264

Snapshot 264

Background 264

Products 264

Major Developments 264

Contact Details 265

USA 266

Acella Pharmaceuticals266

Snapshot 266

Background 266

Products 266

Contact Details 266

Aceto267

Snapshot267

Background 267

Products267

Financials 267

Contact Details 268

Akorn269

xv

Snapshot 269Background 269Products270Financials 271Major Developments 272Contact Details 273Alvogen 274Snapshot274Background 274Products274Major Developments 275Contact Details 277Amerigen Pharmaceuticals278Snapshot278Background 278Products278Major Developments 278Contact Details 280Amneal Pharmaceuticals281Snapshot281Background 281Products281Major Developments 283Contact Details 284Amphastar Pharmaceuticals 285Snapshot 285Background 285Products 285Major Developments 286Contact Details 287Antares Pharma288Snapshot 288Background 288Products 288Financials 289Major Developments 289Contact Details 290Apicore291Snapshot291Background 291Products291Contact Details 292AustarPharma293Snapshot 293Background 293Products 293Major Developments 293Contact Details 294Avanthi295Snapshot 295Background 295Products 295Contact Details 295Bedford Laboratories296Snapshot 296xvi

Background 296

Products 296

Major Developments 298

Contact Details 299

Belcher Pharmaceuticals300

Snapshot 300

Background 300

Products 300

Contact Details 300

Biokey 301

Snapshot301

Background 301

Products301

Contact Details 301

Boca Pharmacal 302

Snapshot302

Background 302

Products302

Major Developments 302

Contact Details 303

Breckenridge Pharmaceutical 304

Snapshot 304

Background 304

Products 304

Major Developments 304

Contact Details 306

Cambrex 307

Snapshot307

Background 307

Products307

Financials 307

Major Developments 308

Contact Details 309

Carlsbad Technology 310

Snapshot310

Background 310

Products310

Contact Details 310

Cephazone Pharma 311

Snapshot311

Background 311

Products311

Contact Details 311

CorePharma 312

Snapshot312

Background 312

Products312

Major Developments 313

Contact Details 313

Cypress Pharmaceutical 314

Snapshot314

Background 314

Products314

Major Developments 314

Contact Details 315

xvii

Elite Pharmaceuticals 316Snapshot316Background 316Products316Financials 316Major Developments 317Contact Details 318Epic Pharma 319Snapshot319Background 319Products319Major Developments 319Contact Details 320EPIRUS Biopharmaceuticals 321Snapshot321Background 321Products321Major Developments 321Contact Details 322Exela 323Snapshot323Background 323Major Developments 323Contact Details 324Ferndale Pharma Group 325Snapshot325Background 325Products325Major Developments 326Contact Details 326Fougera327Snapshot327Background 327Products327Major developments 328Contact Details 329G&W Laboratories330Snapshot330Background 330Products330Contact Details 331GeneraMedix Pharmaceuticals332Snapshot332Background 332Products332Major Developments 333Contact Details 333Greenstone334Snapshot334Background 334Products334Major Developments 334Contact Details 335Handa Pharmaceuticals336Snapshot336xviii

Background 336

Products336

Major Developments 336

Contact Details 337

Hanford Pharmaceuticals338

Snapshot338

Background 338

Products338

Major Developments 338

Contact Details 339

Harris Pharmaceutical340

Snapshot 340

Background 340

Products 340

Contact Details 340

Hi-Tech Pharmacal 341

Snapshot341

Background 341

Products341

Financials 342

Major Developments 343

Contact Details 344

IGI Laboratories 345

Snapshot 345

Background 345

Products 345

Financials 345

Major Developments 346

Contact Details 346

Indicus Pharma347

Snapshot347

Background 347

Products347

Contact Details 348

InvaGen Pharmaceuticals349

Snapshot 349

Background 349

Products 349

Contact Details 350

Kadmon Pharmaceuticals 351

Snapshot351

Background 351

Products351

Major Developments 351

Contact Details 352

Kremers Urban Pharmaceuticals353

Snapshot353

Background 353

Products353

Major Developments 354

Contact Details 354

KVK-Tech 355

Snapshot355

Background 355

Products355

xix

Major Developments 355Contact Details 356Lehigh Valley Technologies357Snapshot357Background 357Products357Major Developments 357Contact Details 358Luitpold Pharmaceuticals359Snapshot359Background 359Products359Major Developments 361Contact Details 362Lyne Laboratories363Snapshot 363Background 363Products 363Contact Details 363Mallinckrodt364Snapshot 364Background 364Products 364Major Developments 365Contact Details 366Mikart367Snapshot367Background 367Products367Contact Details 368Nexgen Pharma369Snapshot 369Background 369Products 369Contact Details 369Nexus Pharmaceuticals370Snapshot370Background 370Products370Major Developments 370Contact Details 371Nostrum Pharmaceuticals372Snapshot372Background 372Products372Major Developments 372Contact Details 373Novel Laboratories 374Snapshot374Background 374Products374Major Developments 375Contact Details 375Orit Laboratories 376Snapshot376xx

Background 376

Products376

Contact Details 376

Osmotica Pharmaceutical377

Snapshot377

Background 377

Products377

Major Developments 378

Contact Details 378

Patheon379

Snapshot379

Background 379

Products379

Financials 380

Major Developments 381

Contact Details 382

Pharmaceutical Associates 383

Snapshot 383

Background 383

Products 383

Contact Details 383

Prasco Laboratories384

Snapshot 384

Background 384

Products 384

Major Developments 384

Contact Details 386

Precision Dose387

Snapshot 387

Background 387

Products 387

Major Developments 387

Contact Details 388

Qualitest Pharmaceuticals 389

Snapshot 389

Background 389

Products 389

Financials 391

Major Developments 392

Contact Details 392

Roxane Laboratories 393

Snapshot393

Background 393

Products393

Major Developments 395

Contact Details 396

Sigmapharm Laboratories 397

Snapshot397

Background 397

Products397

Contact Details 397

Silarx Pharmaceuticals 398

Snapshot 398

Background 398

Products 398

xxi

Contact Details 398SOHM399Snapshot 399Background 399Products 399Financials 399Major Developments 400Contact Details 401Spear Pharmaceuticals402Snapshot 402Background 402Products 402Major Developments 402Contact Details 402Stason Pharmaceuticals403Snapshot 403Background 403Products 403Major Developments 403Contact Details 404Tolmar 405Snapshot 405Background 405Products 405Major Developments 405Contact Details 406Tris Pharma407Snapshot 407Background 407Products 407Major Developments 408Contact Details 408Upsher-Smith Laboratories409Snapshot 409Background 409Products 409Major Developments 410Contact Details 410VersaPharm411Snapshot411Background 411Products411Contact Details 412VistaPharm 413Snapshot413Background 413Products413Contact Details 413X-GEN Pharmaceutical 414Snapshot414Background 414Products414Major Developments 414Contact Details 415xxii

Vietnam416

Nanogen Biopharmaceutical 416

Snapshot416

Background 416

Products416

Contact Details 416

To order this report: Generic Drugs: Global collaboration opportunities http://www.reportlinker.com/p0703654/Generic-Drugs-Global-collaboration-opportunities .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Generic_Drug

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

 

SOURCE Reportlinker



RELATED LINKS
http://www.reportlinker.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.